SOURCE: Universal Detection Technology

November 25, 2008 06:59 ET

Universal Detection Technology Analyzes the Increased Incidence of Both Community and Hospital Acquired MRSA

Company's Vital Oxide Kills 99.9% of Bacteria Including MRSA

LOS ANGELES, CA--(Marketwire - November 25, 2008) - Universal Detection Technology ( (OTCBB: UNDT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, today issued an analysis of the increased incidence of both community and hospital acquired methicillin-resistant Staphylococcus aureus (MRSA).

MRSA is a type of bacteria that is resistant to certain antibiotics. These antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin and amoxicillin. Staph infections, including MRSA, occur most frequently among persons in hospitals and healthcare facilities (such as nursing homes and dialysis centers) who have weakened immune systems.

UNDT's Vital Oxide is truly the Ultimate Odorless Odor Eliminator. Vital Oxide eliminates odors on contact without leaving an odor of its own and actually kills 99.9% of bacteria it comes in contact with, including the MRSA (Super-Bug). Vital Oxide is not a "cocktail" of harmful chemicals that are not good for you or the environment.

The general population learned the extend of the MRSA threat last fall when the Centers for Disease Control and Prevention set off a media frenzy with its announcement that invasive MRSA infections claim at least 18,000 lives a year, more than AIDS. However, MRSA has been quietly killing for decades.

MRSA infections that occur in otherwise healthy people who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are known as community-associated (CA)-MRSA infections. These infections are usually skin infections, such as abscesses, boils, and other pus-filled lesions. (CA)-MRSA has become a growing concern with athletes including the national football league (NFL). According to a recent report on the increased reports of MRSA in the NFL: "MRSA is getting nastier because there are now multiple strains of it and because football is a game where cuts are common. So-called community MRSA is caught in the locker room, then mixes with the nastier type in a hospital when you go in for treatment."

UNDT's line of anti-bacterial sprays have been specifically designed to be effective against MRSA. Studies on the product show that areas treated with the solution not only become disinfected, but also no new stains appear on the treated area for up to 7 days.

"The threat of Community MRSA is becoming more and more evident everyday and we have developed products to counter the threat," said Mr. Jacques Tizabi, UNDT's Chief Executive Officer. "Every school and university needs to implement strict disinfection techniques to insure the safety of the students," he added.

For more information please visit our website at or

Email us at

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The Company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. For more information, please visit

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact Information